MENU

Stressed-out beta cells masters of own demise?
Published on March 30, 2017

The prevailing belief on how type 1 diabetes (T1D) develops is that the immune system mistakenly identifies insulin-producing beta cells as foreign, leading to their destruction. A new study published in Nature Medicine has found beta cells themselves may be causing the destructive immune response that leads to T1D. This is a relatively new concept […]

Share

There are a number of genes linked to type 1 diabetes (T1D), but not everyone with these genes will develop the condition. This suggests that there are likely environmental triggers that stimulate the development of T1D. The Environmental Determinants of Diabetes in the Young (TEDDY), a study part-supported by JDRF, investigates the environmental factors that […]

Share
‘Medicinal food’ diet counters onset of type 1 diabetes
Published on March 28, 2017

A JDRF-supported study has found – for the first time – that a diet that produces high amounts of the short-chain fatty acids acetate and butyrate provided a beneficial effect on the immune system and protected against type 1 diabetes. The specialised diet developed by CSIRO and refined by Monash University researchers uses resistant starches – […]

Share
Exercise and type 1 diabetes: World-first guidelines consensus
Published on February 22, 2017

A report by leading type 1 diabetes experts (T1D) from around the world has for the first time, provided consensus on managing blood glucose levels safely while exercising. The report, ‘Exercise management in type 1 diabetes: a consensus statement’ was published in the Lancet Diabetes and Endocrinology journal and involved a team of 21 researchers, including […]

Share
JDRF T1D Fund launches with USD 42 million in commitments
Published on February 17, 2017

JDRF International, our US counterpart, has launched an early-stage investment fund to catalyse development of commercial type 1 diabetes (T1D) therapies. This initiative brings a venture philanthropy model to the fight against T1D. The JDRF T1D Fund is the first and largest investment vehicle devoted to identifying and funding high impact T1D commercial opportunities in active […]

Share

The Hon Simon Birmingham, Minister for Education and Training, and The Hon Greg Hunt, Minister for Health and Minister for Sport, have today announced the recipients of Innovation Award grants for research into type 1 diabetes. Three bold, promising research projects have been selected and will benefit from $4.5 million in funding from the Type […]

Share
International type 1 diabetes experts converge on Sydney
Published on January 11, 2017

In December, the Type 1 Diabetes Clinical Research Network (T1DCRN) brought together leading national and international experts in type 1 diabetes in Sydney for the 2016 BRIdGE Symposium (Building Research Ideas across Geography and Expertise). This year’s theme was innovation in autoimmunity and complications. A mix of high calibre clinicians, clinical researchers and basic researchers […]

Share
Lab tours take JDRF supporters inside the research
Published on December 8, 2016

We talk to our supporters a lot about the research that’s happening around Australia, but it’s a fairly rare and special experience to actually venture behind the scenes and into the busy labs where the magic is happening. But that’s exactly what’s been going on across Australia during October and November, where JDRF staff in […]

Share
The need to screen for additional autoimmune diseases
Published on November 14, 2016

People with type 1 diabetes (T1D) often develop other autoimmune diseases, but how often and predictive factors for development have not yet been characterised. While researchers are still unlocking the mysteries of why T1D develops, it is thought there are common immune system pathways that may be similar across more than one, or all autoimmune diseases. […]

Share
1 2 3 7